Ads
related to: merck hiv drugs- Side Effects And Safety
Get Important Safety Information
About An HIV Medication.
- Patient Assistance Info
Discover If You Are Eligible To
Save On An HIV-1 Treatment Option.
- Talking To Your Doctor
Find Resources To Talk To Your
Doctor About An HIV-1 Therapy.
- Learn How Treatment Works
Visit The Patient Website To Learn
How An HIV-1 Treatment Works.
- Side Effects And Safety
Search results
Merck to start studying lower dose of HIV drug after FDA hold
Reuters via Yahoo News· 2 years agoThe FDA has reviewed and agreed with the plan to study lower-dose versions of the once-daily pill...
Merck cancer drug deal caps pharma investment influx into ‘ADC’ field
BioPharma Dive via Yahoo Finance· 7 months agoWith the alliance, Merck joins Pfizer, AstraZeneca and Gilead in staking major bets on the potential...
Merck (MRK) Resumes HIV Studies on Islatravir With Lower Dose
Zacks via Yahoo Finance· 2 years agoMerck MRK announced that it will evaluate a lower dose of its HIV candidate islatravir in a phase...
Is Merck Stock A Buy As It Looks To Carve Share In The Cardiovascular Market?
Investor's Business Daily· 1 year agoMerck stock is lingering in a consolidation after the company unveiled promising test results for...
Merck To Start New Islatravir HIV Trials With Lower Dose After FDA Hold
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) will initiate a new Phase 3 program with once-daily islatravir to treat...
Sanders threatens to subpoena J&J, Merck CEOs over drug prices
BioPharma Dive via Yahoo Finance· 4 months agoA Congressional committee may subpoena the CEOs of Johnson & Johnson and Merck & Co. to testify...
Gilead (GILD) & MRK's HIV Oral Combo Shows Efficacy in Phase II
Zacks via Yahoo Finance· 2 months agoGilead (GILD) and Merck's (MRK) phase II study data demonstrates the efficacy of their oral...
Merck (MRK) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 months agoImage source: The Motley Fool. Merck (NYSE: MRK) Q4 2023 Earnings Call Feb 01, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
My Biggest Worry About Gilead Sciences
Motley Fool· 2 years agoIn Q2, HIV drugs generated more than two-thirds of its total revenue. If you delve further into the details, you'll see that two drugs -- Biktarvy and,...
New Daily HIV Pill Moves Closer to Approval
Plus via Yahoo News· 2 years agoGlobal healthcare company Merck recently announced that they will begin a Phase 3 clinical study on the use of the drug islatravir for the treatment of...
Ads
related to: merck hiv drugs
